Tag: cancer
NHS breast cancer screening overhaul
There may be an overhaul into NHS breast cancer screening practices after last year’s scandal that led to some 450,000 women in the UK not receiving their vital invitation for screening.
We were contacted for advice soon after news of the scandal hit the headlines, and we have agreed to take claims for compensation forward on a No Win, No Fee basis. Our legal action is underway, and this is one of the over 40 different group and multi-party actions our lawyers are fighting for justice in.
If you were affected by last year’s screening scandal and you’ve yet to start your claim with us, we can offer you free, no-obligation advice now. As we approach the one-year anniversary of the breaking of the issue, we may be set to see a serious overhaul when it comes to how the NHS manages their screening services.
NHS breast screening problems: Legal Advice!
If you have had NHS breast screening problems, you may be entitled to make a claim for compensation if something has gone horribly wrong.
We’re involved in legal action over the 2018 breast cancer screening scandal where some half a million women didn’t receive their invitation for life-saving checks. The issue arose from a simple IT error that means the letters didn’t go out, and it’s suspected that hundreds of women may have died as a result.
Our lawyers can help you if you have been the victim of NHS breast screening problems like the 2018 scandal. Read more about what we may be able to do for you below.
Breast cancer screening compensation
If you’ve yet to touch base with us about your No Win, No Fee options for breast cancer screening compensation, please get in touch as soon as you can.
We’re involved in legal action breast cancer screening compensation for the scandal that hit the media last year. This was the IT glitch that cut the age off of letter being sent to the vulnerable group (aged between 68 and 71). The result of the glitch meant some 450,000 women may not have receive their potentially life-saving invitation for breast cancer screening.
Shortly after the news of the scandal hit the press, we were contacted for help. We’ve agreed to act for women affected by the scandal on a No Win, No Fee basis.
40,000 patients affected by cervical screening error
Some 40,000 patients are affected by the recent cervical screening error that has led to thousands of letters not being sent out.
Of the 40,000 affected, some 4,000 were in relation to test results that never went out. Up to 200 of those reportedly showed abnormal results where women will have likely needed swift intervention if cancer has been identified.
The number of patients affected is staggering, and this isn’t the first time a simple error has led to a significant blunder of this nature. We’re representing victims of the NHS breast screening scandal where letters for screening didn’t go out due to an IT error.
The Roundup weed killer cancer lawsuit
The Roundup weed killer cancer lawsuit alleges that the product can be carcinogenic. The ingredient at the heart of the case is glyphosate.
Although makers of Roundup, Monsanto, are fiercely defending the hundreds of claims brought against them, a claim has settled to the tune of over £200m. Monsanto say there is no viable evidence that glyphosate causes cancer. The common herbicide is found in many household and farming products.
The Roundup weed killer cancer lawsuits allege that glyphosate is carcinogenic. Opinions remain divided.
Johnson & Johnson talcum powder and cancer link investigations to begin in the UK
The latest Johnson & Johnson talcum powder cancer trial in the US has concluded with the victim awarded $40m in damages.
The Claimant alleged that his mesothelioma – an aggressive and incurable cancer – was caused by long-term use of J & J talc. In light of key expert evidence that indicated there can be trace amounts of asbestos contained in talcum powder, he has won his case.
There are currently thousands of similar lawsuits in the US, and our Group Action Lawyers are ready to investigate UK cases also.
Continue Reading…
Johnson & Johnson talcum powder asbestos case: victim awarded $40m in compensation
The verdict is in for the J&J talcum powder cancer cases, with damages awarded in what is one of the biggest cases of our time.
Johnson & Johnson, together with one of its suppliers, are being ordered to pay out around $40m in damages to one victim who developed mesothelioma, which he claimed had been caused through the use of J&J talcum powder since birth.
Experts called to trial stated that they believe the talc does contain asbestos due to cross-contamination, and claims have also been made that J&J knew about the dangers but allegedly duped regulators and kept the issues quiet by using tests that would not identify asbestos.
Continue Reading…
Jonson & Johnson baby power contained asbestos, expert warns
There are numerous reports of people allegedly developing cancer as a result of using Johnson & Johnson baby power which, according to several legal cases, has at least previously been found to have contained asbestos.
An expert from an asbestos laboratory giving evidence in one compensation claim said that multiple studies had found asbestos contained in J & J talcum powder products. The evidence may prove pivotal for the case in question, as well as for many other cases against Johnson & Johnson, who have been vigorously defending legal actions against them for years.
Continue Reading…
All hormonal contraception like ‘the pill’ can still increase breast cancer risks
It has been reportedly known for a while that forms of hormonal contraception like ‘the pill’ have been linked with increased risks of women developing breast cancer. However, despite hopes of improvements, a new study involving millions of women over a period of years has reaffirmed the apparent risks associated with contraception and cancer.
Studies have found that the increased risks of breast cancer can remain until five years after hormonal contraception has been stopped as well.
Continue Reading…
Lab error leads to thousands of cervical screening tests being reviewed
A laboratory run by Pathology First, working on behalf of Basildon and Thurrock NHS Foundation Trust, are having to redo thousands of cervical screening tests for cancer after an error was discovered.
The samples affected, which were taken between April 2016 and September 2017 for women aged between 24 and 29 who had smear tests, as well as a number of women in their 60’s, are being re-screened independently.
The results held by the lab were classed as negative, but having had some 2,500 samples re-screened, 17 women have reportedly been invited for further assessments.
Continue Reading…